NDI draft guidance

ODI docket comments:  Make the list big, or don’t make it at all

Archive article of the week

ODI docket comments: Make the list big, or don’t make it at all

By Hank Schultz

Will compiling an official list of Old Dietary Ingredients ultimately be worth the effort? Maybe, but the resulting list must be expansive rather than restrictive to be of much use, most stakeholders agree.

© Getty Images / jcamilobernal

The 18 things we learned from the IPA’s DC Workshop 2017

By Stephen Daniells

From market sizing to the need for global probiotics standards at Codex, the International Probiotic Association’s second DC workshop in collaboration with the US Pharmacopeia succeeded in providing a venue for sharing knowledge and expertise.

FDA continuing to drill down to provenance of ingredients

FDA continuing to drill down to provenance of ingredients

By Hank Schultz

Recent warning letters show the Food and Drug Administration continues to hone in on the provenance of ingredients, and demonstrate that the tempo of enforcement remains unchanged despite the moves by the Trump Administration to roll back regulations...

Follow us

Featured Events

View more

Products

View more

Webinars